AAPG
HEALTHCAREAscentage Pharma Group International
AI Insight
What's Moving AAPG Today?
No stock-specific AI insight has been generated for AAPG yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$16.92$48.45
$17.18
Fundamentals
Market Cap$1.6B
P/E Ratio—
EPS$-2.07
Dividend Yield—
Dividend / Share—
ROE-154.6%
Profit Margin-216.5%
Debt / Equity—
Trading
Volume11K
Avg Volume (10D)—
Shares Outstanding93.3M
AAPG News
24 articles- Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 CongressThe Manila Times·Jun 15, 2026
- Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 CongressGlobeNewswire Inc.·Jun 14, 2026
- A Look At Ascentage Pharma Group International’s Valuation After Recent Share Price WeaknessYahoo Finance·Jun 8, 2026
- Ascentage Pharma (AAPG) Reports Phase 1b Olverembatinib DataYahoo Finance UK·Jun 5, 2026
- Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026lincolnjournal.com·Jun 1, 2026
- Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026Yahoo! Finance Canada·Jun 1, 2026
- Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026GlobeNewswire Inc.·May 31, 2026
- Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026GlobeNewswire Inc.·May 31, 2026
- Ascentage Pharma Announces Trustee Purchase of Shares for 2022 RSU Scheme on May 28, 2026Minichart·May 29, 2026
- Global Growth Companies Insiders Favor With Up To 40% Earnings GrowthYahoo Finance·May 25, 2026
- ASCO trial sees 30% response in pediatric tumors on Ascentage comboStock Titan·May 22, 2026
- Ascentage Pharma Releases Latest Clinical Data from Multiple Trials at ASCO 2026Yahoo Finance·May 22, 2026
- Ascentage Pharma to Present 17 Clinical Advances at 2026 European Hematology Association CongressGlobeNewswire Inc.·May 13, 2026
- Ascentage Pharma to Participate in Three Upcoming Investor ConferencesYahoo Finance·May 12, 2026
- Global Growth Companies With High Insider Ownership In April 2026Yahoo Finance·Apr 22, 2026
- Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026GlobeNewswire Inc.·Apr 22, 2026
- Global Growth Companies With High Insider OwnershipYahoo Finance·Apr 20, 2026
- Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual MeetingYahoo Finance·Apr 20, 2026
- Global Insights Into 3 Growth Stocks With High Insider OwnershipYahoo Finance·Apr 17, 2026
- Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer SaysYahoo Finance·Mar 27, 2026
- Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business UpdatesGlobeNewswire Inc.·Mar 25, 2026
- Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026Yahoo Finance·Mar 18, 2026
- Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026Yahoo Finance·Mar 11, 2026
- A Look At Ascentage Pharma Group International’s Valuation After Recent Share Price MovesYahoo Finance·Mar 9, 2026
All 24 articles loaded
Price Data
Open$17.03
Previous Close$17.13
Day High$17.23
Day Low$17.01
52 Week High$48.45
52 Week Low$16.92
52-Week Range
$16.92$48.45
$17.18
Fundamentals
Market Cap$1.6B
P/E Ratio—
EPS$-2.07
Dividend Yield—
Dividend / Share—
ROE-154.6%
Profit Margin-216.5%
Debt / Equity—
Trading
Volume11K
Avg Volume (10D)—
Shares Outstanding93.3M
About Ascentage Pharma Group International
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company is headquartered in Suzhou, China.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—